Home » Topics » Regulatory » Patents

Patents
RSS

KEAP1/NRF2 interaction inhibitors presented by Ube Industries

Dec. 17, 2020

Shanghai Zhimeng Biopharma presents new KCNQ2 activators

Dec. 17, 2020

Galapagos discloses new SIK inhibitors

Dec. 17, 2020

Sichuan Haisco Pharmaceutical patents CRBN-comprising PROTACs

Dec. 17, 2020

Duke University presents new pro-N-cadherin-targeting humanized antibodies

Dec. 16, 2020

Merck & Co. discovers new compounds for HIV infection

Dec. 16, 2020

Medshine Discovery identifies new RIP-1 inhibitors

Dec. 16, 2020

Merck & Co. patents NPR1 agonists

Dec. 16, 2020

Voronoi discloses new RET inhibitors

Dec. 16, 2020

Suzhou Ribo Life Science describes new PCSK9-targeting siRNA

Dec. 15, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...